DELCURATOLO, MARCO DONATELLO
 Distribuzione geografica
Continente #
NA - Nord America 396
EU - Europa 191
AS - Asia 142
AF - Africa 2
OC - Oceania 2
Totale 733
Nazione #
US - Stati Uniti d'America 394
SG - Singapore 82
IT - Italia 78
IE - Irlanda 50
SE - Svezia 28
CN - Cina 22
HK - Hong Kong 11
ID - Indonesia 8
BE - Belgio 7
VN - Vietnam 7
FI - Finlandia 6
ES - Italia 5
GB - Regno Unito 5
IN - India 4
JP - Giappone 4
UA - Ucraina 4
DE - Germania 3
KR - Corea 3
CA - Canada 2
FR - Francia 2
NG - Nigeria 2
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
FJ - Figi 1
GE - Georgia 1
NL - Olanda 1
Totale 733
Città #
Santa Clara 86
Singapore 72
Chandler 63
Dublin 50
Nyköping 23
Columbus 15
Turin 15
Fairfield 13
Milan 11
Jakarta 8
Torino 8
Hong Kong 7
Medford 7
Princeton 7
Cambridge 6
Ann Arbor 5
Ashburn 5
Hebei 5
Naples 5
Helsinki 4
Houston 4
Molenbeek-Saint-Jean 4
Boston 3
Brussels 3
Dong Ket 3
Hangzhou 3
Rome 3
Seoul 3
Abuja 2
Beijing 2
Chennai 2
Dalmine 2
Dubino 2
Ferrol 2
Guiyang 2
Lappeenranta 2
London 2
New York 2
Norwalk 2
Padova 2
San Diego 2
Toronto 2
Vigo 2
Ōtemae 2
Amsterdam 1
Bordeaux 1
Chicago 1
Cuneo 1
Falconara Marittima 1
Falls Church 1
Glasgow 1
Grugliasco 1
Guangzhou 1
Hornsby 1
Hyderabad 1
Kunming 1
Lanzhou 1
Latina 1
Madrid 1
Modena 1
Moncalieri 1
Mountain View 1
Munich 1
Okayama 1
Piemonte 1
Redmond 1
San Mateo 1
Seattle 1
Shanghai 1
Suva 1
Tbilisi 1
Tokyo 1
Tolentino 1
Upper Marlboro 1
Washington 1
Wilmington 1
Xingtai 1
Totale 506
Nome #
Immune-checkpoint inhibition in stage III unresectable NSCLC: Challenges and opportunities in the post-PACIFIC era 85
Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside 73
Luteinized thecoma (thecomatosis) with sclerosing peritonitis: a systematic review of the literature of the last 25 years 69
Black Hairy Tongue After Immune Checkpoint Inhibitors in NSCLC: A Case Report and Review of the Literature 67
NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images 67
Major breakthroughs in lung cancer adjuvant treatment: Looking beyond the horizon 62
Discrepancy between tumor response and hematologic response in a patient with thymoma and aplastic anemia treated with ciclosporin 49
Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine? 47
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy 44
Therapeutic sequencing in advanced renal cell carcinoma: how to choose considering clinical and biological factors 40
New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond 36
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed 29
Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients-An Italian Single-Center Experience 29
Navigating the ICI Combination Treatment Journey: Patterns of Response and Progression to First-Line ICI-Based Combination Treatment in Metastatic Renal Cell Carcinoma 27
Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis 17
Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives 13
Totale 754
Categoria #
all - tutte 4.368
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.368


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 0 0 0 15
2021/2022127 13 2 5 1 10 10 12 5 5 9 35 20
2022/2023240 12 21 5 17 25 64 18 17 32 3 18 8
2023/2024120 19 21 6 5 2 8 8 4 3 16 15 13
2024/2025252 6 41 19 44 103 39 0 0 0 0 0 0
Totale 754